Intas Pharmaceuticals files DRHP for IPO
The IPO will be made through a public issue of equity shares of face value of Rs 10 each
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
MoHFW to set up four member committee to regulate stem cell and other cell-based therapies
Committee to submit report within next two months of its formation
Merial’s acquisition of animal health division of Dosch Pharmaceuticals closes in India
The acquired business, Sanofi Synthelabo India, will market Dosch’s 86 animal health products and 50 brands for ruminants, poultry…
US FDA approves Xgeva to treat giant cell tumour of the bone
Xgeva is a monoclonal antibody that binds to RANKL, a protein essential for maintenance of healthy bone
DIPP invites views on proposed changes in patent fee structure
Proposes doubling patent fee; 10 per cent surcharge on hard copy filing
Sotax Group to shift Asia-Pacific headquarters from China to India
Acquires Dr Schleuniger Pharmatron for $15 million
Drugs, vaccines excluded from exemption extension of TRIPS-related IP
MSF calls decision a "half-hearted compromise
Deutsche Post DHL partners with Teach For All
Expands its worldwide efforts to promote educational opportunities through extended partnership with
Hovione appoints Justin Hughey, to lead particle design sciences
Hughey earned his Ph.D. in pharmaceutics from The University of Texas at Austin